药物对比
Linagliptin vs Gliquidone
比较 Linagliptin（Tradjenta）与 Gliquidone 治疗2型糖尿病。DPP-4与磺脲类：低血糖风险、体重影响和患者适用性。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when choosing between a DPP-4 inhibitor and a sulfonylurea for type 2 diabetes patients at risk of hypoglycemia.
结论
The preferred agent depends on patient-specific risks such as hypoglycemia, weight, and cost rather than one being inherently superior.
全部药物对比